98 related articles for article (PubMed ID: 31574205)
1. ZNF703 is an important player in head and neck cancer.
Orhan C; Bakır B; Dalay N; Buyru N
Clin Otolaryngol; 2019 Nov; 44(6):1080-1086. PubMed ID: 31574205
[TBL] [Abstract][Full Text] [Related]
2. ZNF703 Overexpression may act as an oncogene in non-small cell lung cancer.
Baykara O; Dalay N; Kaynak K; Buyru N
Cancer Med; 2016 Oct; 5(10):2873-2878. PubMed ID: 27650486
[TBL] [Abstract][Full Text] [Related]
3. Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma.
Yang H; Jiang WQ; Cao Y; Sun YA; Wei J; An X; Zhang YC; Song M; Wang SS; Yuan ZY; Peng RJ; Chen TH; Li LR; Shi YX
Dis Markers; 2015; 2015():640263. PubMed ID: 26063961
[TBL] [Abstract][Full Text] [Related]
4. The effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC.
Ekizoglu S; Dogan S; Ulker D; Seven D; Gozen ED; Karaman E; Buyru N
Clin Otolaryngol; 2015 Dec; 40(6):622-8. PubMed ID: 25850957
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
8. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1-induced proliferation is independent of beta-catenin in head and neck cancer.
Sales KU; Giudice FS; Castilho RM; Salles FT; Squarize CH; Abrahao AC; Pinto DS
Oral Dis; 2014 Apr; 20(3):e42-8. PubMed ID: 23730900
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma.
Kyomoto R; Kumazawa H; Toda Y; Sakaida N; Okamura A; Iwanaga M; Shintaku M; Yamashita T; Hiai H; Fukumoto M
Int J Cancer; 1997 Dec; 74(6):576-81. PubMed ID: 9421351
[TBL] [Abstract][Full Text] [Related]
11. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
[TBL] [Abstract][Full Text] [Related]
12. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
[TBL] [Abstract][Full Text] [Related]
14. The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies.
Vander Broek R; Mohan S; Eytan DF; Chen Z; Van Waes C
Oral Dis; 2015 Oct; 21(7):815-25. PubMed ID: 24219320
[TBL] [Abstract][Full Text] [Related]
15. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
17. Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
Wang Y; Chen C; Wang X; Jin F; Liu Y; Liu H; Li T; Fu J
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2461-2468. PubMed ID: 27601166
[TBL] [Abstract][Full Text] [Related]
18. High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer.
Reynisdottir I; Arason A; Einarsdottir BO; Gunnarsson H; Staaf J; Vallon-Christersson J; Jonsson G; Ringnér M; Agnarsson BA; Olafsdottir K; Fagerholm R; Einarsdottir T; Johannesdottir G; Johannsson OT; Nevanlinna H; Borg A; Barkardottir RB
Cancer Med; 2013 Aug; 2(4):437-46. PubMed ID: 24156016
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
[TBL] [Abstract][Full Text] [Related]
20. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
